Quantity and diversity of environmental microbial exposure and development of asthma : a birth cohort study by Karvonen, AM et al.
ORIGINAL ARTICLE EP IDEMIOLOGY AND GENETICS
Quantity and diversity of environmental microbial
exposure and development of asthma: a birth cohort study
A. M. Karvonen1, A. Hyv€arinen1, H. Rintala1, M. Korppi2, M. T€aubel1, G. Doekes3, U. Gehring3,
H. Renz4, P. I. Pfefferle4, J. Genuneit5, L. Keski-Nisula1,6, S. Remes7, J. Lampi1,8, E. von Mutius9 &
J. Pekkanen1,8
1Department of Environmental Health, National Institute for Health and Welfare, Kuopio; 2Pediatric Research Center, University of Tampere
and University Hospital, Tampere, Finland; 3Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands; 4Institute
for Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps-University Marburg, Marburg; 5Institute of Epidemiology and
Medical Biometry, Ulm University, Ulm, Germany; 6Departments of Obstetrics and Gynecology, Kuopio University Hospital; 7Department of
Pediatrics, Kuopio University Hospital; 8Unit of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland; 9Children’s
Hospital, University of Munich, Munich, Germany
To cite this article: Karvonen AM, Hyv€arinen A, Rintala H, Korppi M, T€aubel M, Doekes G, Gehring U, Renz H, Pfefferle PI, Genuneit J, Keski-Nisula L, Remes
S, Lampi J, von Mutius E, Pekkanen J. Quantity and diversity of environmental microbial exposure and development of asthma: a birth cohort study. Allergy 2014;
69: 1092–1101.
Keywords
asthma; atopy; children; microbial exposure;
respiratory tract disease.
Correspondence
Anne M. Karvonen, Department of
Environmental Health, National Institute for
Health and Welfare, P.O. Box 95, FIN-70701
Kuopio, Finland.
Tel.: +358 (0) 29 524 6325
Fax: +358 (0) 29 524 6498
E-mail: anne.karvonen@thl.fi
Accepted for publication 27 April 2014
DOI:10.1111/all.12439
Edited by: Douglas Robinson
Abstract
Background: Early-life exposure to environmental microbial agents may be asso-
ciated with the development of allergies. The aim of the study was to identify bet-
ter ways to characterize microbial exposure as a predictor of respiratory
symptoms and allergies.
Methods: A birth cohort of 410 children was followed up until 6 years of age.
Bacterial endotoxin, 3-hydroxy fatty acids, N-acetyl-muramic acid, fungal extra-
cellular polysaccharides (EPS) from Penicillium and Aspergillus spp., b-D-glucan,
ergosterol, and bacterial or fungal quantitative polymerase chain reactions
(qPCRs) were analyzed from dust samples collected at 2 months of age. Asthma,
wheezing, cough, and atopic dermatitis were assessed using repeated question-
naires. Specific IgEs were determined at the age of 1 and 6 years.
Results: Only few associations were found between single microbial markers and
the studied outcomes. In contrast, a score for the total quantity of microbial expo-
sure, that is, sum of indicators for fungi (ergosterol), Gram-positive (muramic
acid) bacteria, and Gram-negative (endotoxin) bacteria, was significantly
(inverted-U shape) associated with asthma incidence (P < 0.001): the highest risk
was found at medium levels (adjusted odds ratio (aOR) 2.24, 95% confidence
interval (95% CI) 0.87–5.75 for 3rd quintile) and the lowest risk at the highest
level (aOR 0.34, 95% CI 0.09–1.36 for 5th quintile). The microbial diversity score,
that is, sum of detected qPCRs, was inversely associated with risk of wheezing
and was significantly (inverted-U shape) associated with sensitization to inhalant
allergens.
Conclusion: Score for quantity of microbial exposure predicted asthma better
than single microbial markers independently of microbial diversity and amount of
dust. Better indicators of total quantity and diversity of microbial exposure are
needed in studies on the development of asthma.
Microbial exposure may contribute to the development of
allergic diseases, but the role of different agents and mecha-
nisms are still unknown (1). Most epidemiological studies
with microbial exposure assessment among children have
been restricted to studies on endotoxin (2) or have used only
a limited set of microbial markers (3–7). These microbial
markers reflect typically only a narrow part of the total
microbial exposure. Recently, some studies have applied
combined indicators of microbial exposure (8, 9), like diver-
sity of microbes, which appears to have a protective effect on
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the development of asthma (8). Thus, there is a clear need to
use combined indicators and other new approaches to
describe exposure to environmental microbes.
The objective of this study was therefore to study prospec-
tively the associations between several markers of environmen-
tal microbial exposure—including their combinations—and
the development of doctor-diagnosed asthma, respiratory
symptoms, atopic dermatitis, and sensitization up to the age of
6 years.
Methods
The study population consisted of children born in Eastern
and Middle Finland: the first half of the study population
(N = 214) belongs to a European birth cohort (PASTURE)
(10) among farmers and nonfarmers, while the second half of
the cohort is an extension to unselected children (N = 228)
(11). Pregnant women were recruited, whose children were
born between September 2002 and May 2005. The study pro-
tocol was approved by a local ethics committee in Finland
(11). A written informed consent was obtained from the
parents.
Follow-up
The first questionnaire was administered during the third
trimester of pregnancy (11). The follow-up questionnaires
(at the age of 2, 12, 18, and 24 months, and thereafter
annually), except the questionnaire at 2 months, enquired
about any wheezing, other respiratory symptoms apart from
cold (wheezing, cough, nocturnal cough), and confounders
for the time period after the preceding questionnaire.
‘Asthma ever’ was defined as first parent-reported doctor-
diagnosed asthma and/or second diagnoses of asthmatic (or
obstructive) bronchitis. ‘Current asthma’ was defined as
those asthma ever cases who also reported the use of
asthma medication and/or wheezing in past 12 months in
the 6-year follow-up. ‘Atopic dermatitis ever’ was defined as
first parent-reported doctor-diagnosed atopic dermatitis dur-
ing the follow-up.
House dust samples
The protocols for dust collection are explained in detail in
the Supplementary material. Briefly, in the Finnish PAS-
TURE study, fieldworkers took two samples from living
room floors for the present report. The first samples were
processed without sieving at Utrecht University, where they
were extracted and analyzed for endotoxin (as a marker of
Gram-negative bacteria) and EPS as described previously
(12), and the stored residue after extraction was later ana-
lyzed for b(1,3)-glucans (as a marker of fungal biomass) by
heat extraction and inhibition enzyme immunoassay (EIA)
(13). The second samples were processed and analyzed at
National Institute for Health and Welfare (THL), where they
were sieved to remove larger particles, dried, split and then
stored, and finally analyzed for muramic acid (as a marker of
Gram-positive bacteria), ergosterol (as a marker of fungal
biomass), and lipopolysaccharide (LPS10:0–16:0) (as a marker
of Gram-negative bacteria) by gas chromatography tandem
mass spectrometry (GC-MS–MS) (14) and by quantitative
polymerase chain reaction (qPCR) for microbial DNA
(15–17).
In the extended cohort, results from only one dust sample
from the living room floor collected by the families are used
in the present report. The sample was sieved and dried at
THL, then split in aliquots for various analyses: One aliquot
was sent to Utrecht where it was extracted and analyzed for
endotoxin, EPS, and b(1,3)-glucans (13), and other aliquots
were analyzed for the chemical markers (muramic acid,
ergosterol, LPS10:0–16:0) (14) and microbial DNA (15–17).
Quantitative polymerase chain reaction (qPCR) (15–17)
was used to determine microbes that have been suggested to
be common in moisture-damaged buildings: two genera of
Gram-positive bacteria, Mycobacterium spp. and Streptomy-
ces spp., and six fungal species, genera, or groups: the assay
group for Aspergillus fumigatus/Neosartorya fischeri (AspNeo
group); Cladosporium spp.; the combined assay group for
Penicillium spp., Aspergillus spp., and Paecilomyces variotii
(PenAsp group); Stachybotrys chartarum; Trichoderma viride/
atroviride/koningii (Trichoderma viride group); and Wallemia
sebi.
Exposure to all markers was expressed as loads, that is, the
amount per m2 sampling surface. As the laboratory proce-
dures determine concentrations (agents per mg dust), loads
are calculated by multiplying the concentrations with the mea-
sured dust weight per m2. However, as endotoxin, EPS, and
glucans in the PASTURE samples were determined in nonsi-
eved dust, while all other analyses were performed with sieved
dust, we calculated loads for the former parameters by multi-
plying with the load of sieved dust in the parallel sample taken
for the other analyses. Weights for these parallel sieved and
nonsieved dust samples in the Finnish PASTURE study
showed a fair correlation (Spearman r = 0.7), but with a sys-
tematic difference: as expected, sieved dust samples contained
on average 60% (95% CI 57, 64) less dust. Mean concentra-
tions in sieved and nonsieved dust from nonfarm homes were,
however, very similar, which suggests that endotoxin, EPS, or
glucans are not preferentially bound to the smaller (sieved) or
larger (removed by sieving) particle fractions.
Abbreviations
EPS, fungal extracellular polysaccharide antigens of Penicillium and Aspergillus species; GC-MS–MS, gas chromatography tandem mass
spectrometry; LPS, lipopolysaccharide; LPS10:0-:16:0:0, amount (mol) of LPS in each sample. The number of mol of 3-hydroxy fatty acids of
C10:0 to C16:0 carbon chain length divided by 4; qPCR, quantitative polymerase chain reaction; PASTURE, Protection against Allergy STUdy in
Rural Environments; OR, odds ratio; aOR, adjusted odds ratio; sIgE, specific immunoglobulin E; kU/L, kilo units per liter; GEE, general
estimating equations; EIA, inhibition enzyme immunoassay.
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Blood sampling
Venous blood samples collected at one (N = 374) and at
6 years of age (N = 304) were analyzed for specific immuno-
globulin E (sIgE) to 13 inhalant (Dermatophagoides pteronys-
sinus, D. farinae, alder, birch, European hazel, grass pollen
mixture, rye, mugwort, plantain, cat, horse and dog dander,
and Alternaria alternata) and 6 food allergens (hen’s egg,
cow’s milk, peanut, hazelnut, carrot, and wheat) (Mediwiss
Analytic, Moers, Germany) (18). The cutoff levels for sIgE
concentrations were 0.35 kU/l at one and 0.70 kU/l at
6 years of age. The higher cutoff was used at the age of
6 years due to high prevalence of sensitization (Table 1).
Statistical analyses
Generalized estimating equations (GEE) with an exchange-
able correlation structure to account for correlation between
repeated measures within subjects were used to determine
associations between microbial exposure and repeated mea-
sures of parent-reported wheezing and cough at different
ages. Survival analyses (discrete-time hazard models) were
used in analyzing asthma ever, current asthma, and atopic
dermatitis ever. Logistic regression was used to analyze sensi-
tization to inhalant allergens. The results are presented as
adjusted odds ratios (aORs) and their 95% confidence inter-
vals (95% CI).
In the analysis of single microbial markers, the amounts of
dust and microbial markers were generally divided into three
categories using tertiles as cutoffs. For Wallemia sebi, the
lowest category consisted of levels below the limit of detec-
tion (37.4%) and the rest of the values were evenly divided
into two groups (medium and high). Stachybotrys chartarum
and AspNeo group were dichotomized at the detection level
due to high numbers of nondetected values. Microbial diver-
sity score was defined as the sum of all the detected qPCR
markers (range 0–8). Due to a low number of observations
with low and high diversity, the variable was categorized into
four classes: 0–4, 5, 6, and 7–8.
Total microbial quantity score was calculated as the sum
of three markers for the three different microbial groups, that
is, for fungi, Gram-negative bacteria, and Gram-positive bac-
teria (one marker per group). Single markers were first
divided into five groups using quintiles as cutoffs with scores
0, 1, 2, 3, and 4 from lowest to highest and then summed.
Table 1 Incidence of doctor-diagnosed asthma and atopic dermatitis and the point prevalence of respiratory symptoms during the first
6 years and prevalence of sensitization to inhalant allergens at the age of 1 and 6 years
At 1 year At 1.5 years At 2 years At 3 years At 4 years At 5 years At 6 years
N n % N n % N n % N n % N n % N n % N n %
Asthma ever* 389 6 1.5 353 9 2.6 332 14 4.2 291 15 5.2 271 9 3.3 257 6 2.3 247 3 1.2
Current
asthma†
353 3 0.9 331 7 2.1 315 8 2.5 290 7 2.4 281 3 1.1 274 4 1.5 270 3 1.1
Wheezing
Apart from
cold
391 41 10.5 358 24 6.7 358 25 7.0 338 23 6.8 358 29 8.1 346 22 6.4 357 25 7.0
Any 391 91 23.3 358 58 16.2 358 67 18.7 339 65 19.2 358 68 19.0 348 46 13.2 357 51 14.3
Cough
Apart from
cold
391 98 25.1 358 66 18.4 358 85 23.7 338 80 23.7 357 91 25.5 348 87 25.0 357 94 26.3
Nocturnal 386 18 4.7 358 47 13.1 358 76 21.2 338 63 18.6 357 78 21.9 348 59 17.0 357 79 22.1
Atopic
dermatitis ever‡
390 61 15.6 300 24 8.0 265 12 4.5 230 14 6.1 211 9 4.3 199 7 3.5 188 2 1.1
Sensitization
to inhalant
allergens§
374 78 20.9 304 115 37.8
N = in respirtory symptoms: total number of children with information on given symptom at each follow-up; in sensitization: total number of
children with IgE results at a given time point; in asthma ever: total number of children at each follow-up who has information on asthma
ever at each follow-up and has not censored from the follow-up due to onset of asthma ever; in current asthma: total number of children at
each follow-up who has information on asthma ever and asthma medication/any wheezing at each follow-up and has not censored from the
follow-up due to onset of current asthma; in atopic dermatitis ever: total number of children at each follow-up who has information on atopic
dermatitis at each follow-up and has not censored from the follow-up due to onset of atopic dermatitis. n = the number of children with the
presence of wheezing/cough symptom or with positive IgE result, or the number of newly diagnosed asthma/current asthma/atopic dermati-
tis cases at each follow-up.
*Doctor-diagnosed asthma ever is defined as doctor-diagnosed asthma at least once and/or doctor-diagnosed asthmatic bronchitis more than
once during the 6-year follow-up.
†Current asthma is defined as asthma ever with asthma medication and/or wheezing symptom past 12 months at the age of 6 years.
‡Atopic dermatitis ever is defined as docotor-diagnosed astopic dermatitis during the follow-up.
§Atopic sensitization is defined as any inhalant sIgE ≥0.35 kU/l at the age of 1 year and ≥0.70 kU/l at the age of 6 years.
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All possible combinations with measured microbial markers
were used to create four different total quantity scores for
microbial exposure: (1) ergosterol, endotoxin, and muramic
acid; (2) b-D-glucan, endotoxin, and muramic acid; (3) ergos-
terol, LPS10:0-16:0, and muramic acid; and (4) b-D-glucan,
LPS10:0-16:0, and muramic acid. The created variables, with
ranges from 0 to 12, were divided into five groups using
quintiles as cutoffs for statistical analyses. Linear and qua-
dratic trends in the associations between microbial diversity
or total quantity scores and health outcomes were tested
using polynomial contrasts (19).
All models were adjusted for study cohort, farming, and
well-known risk factors for asthma (maternal history of aller-
gic diseases, gender, number of older siblings, smoking dur-
ing pregnancy). The models of total microbial quantity score
(ergosterol, endotoxin, and muramic acid) and asthma ever,
atopic dermatitis ever, and sensitization to inhalant allergen
were carefully tested for 20 additional confounding factors,
which have been described earlier (12). If a confounder chan-
ged the estimates of the total microbial quantity score by
more than 10%, all the models of the outcome were adjusted
for the factor. All the models of respiratory symptoms and
current asthma were adjusted for the same confounding fac-
tors as in the asthma ever models. Given an exposure preva-
lence of 25%, power calculations (b = 80%, a = 0.05) show
that with these data, we can detect an odds ratio of 2.52 for
asthma ever with a population prevalence of 14%. The data
were analyzed using SAS 9.2 for Windows (SAS lnc., Cary,
NC, USA).
Results
The present analyses included all those 410 children with
data on at least one microbial marker available in any of the
quantity scores. Of those, 341 (83%) had the results of all
microbial determinations. During the 6-year follow-up, 62 of
389 children with data on asthma developed asthma, and
of those children, 35 still had current asthma at the age of
6 years (Table 1). Distributions of all microbial markers are
shown in Table 2.
Most correlations between the amount of house dust and
single microbial markers as well as intercorrelations between
two microbial markers together were between 0.30 and 0.85
(Table S1). Total microbial quantity scores were correlated
Table 2 Levels of microbial markers
N <LOD* (%)
Percentiles
25th Median 75th 95th
Amount of dust (mg/m2)† 410 0 173 311 587 1332
Gram-positive bacteria or marker of Gram-positive bacteria
Mycobacterium (cells/m2) 399 21 (5.3) 186 857 641 427 1 753 136 7 041 045
Streptomyces (cells/m2) 399 7 (1.8) 3923 13 089 45 939 462 289
Muramic acid (ng/m2) 386 7 (1.8) 3122 6616 13 713 34 852
Marker of Gram-negative bacteria
LPS 10:0–16:0 (nmol/m
2) 398 2 (0.5) 3 8 15 46
Endotoxin (EU/m2) 372 0 2668 6253 13 485 66 569
Fungi or marker of fungi
PenAsp group (cells/m2) 399 3 (0.8) 13 580 59 405 233 616 1 282 236
Trichoderma viride group (cells/m2) 400 62 (15.5) 340 2028 9906 153 816
Wallemia sebi (cells/m2) 400 152 (38.0) 0 883 11 541 152 041
Cladosporium (cells/m2) 399 50 (12.5) 3652 25 683 104 690 982 138
AspNeo group (cells/m2) 400 320 (80.0) 0 0 0 14 254
Stachybotrys chartarum (cells/m2) 400 390 (97.5) 0 0 0 0
EPS (EPSU/m2) 374 15 (2.1) 7079 15 312 38 025 126 107
b-D-glucan (lg/m2) 376 0 511 970 1818 4066
Ergosterol (ng/m2) 401 0 1473 3015 7040 21 978
Quantity scores
Ergosterol, endotoxin,
and muramic acid
347 3 6 9 12
b-D-glucan, endotoxin,
and muramic acid
352 3 6 9 12
Ergosterol, LPS10:0–16:0,
and muramic acid
380 3 6 9 12
b-D-glucan, LPS10:0–16:0,
and muramic acid
354 3 7 9 12
Diversity score‡ 399 5 6 6 7
*LOD = the level of detection, percentage of samples under detection level from analyzed samples (%).
†The amount of dust refers to dust samples used for analyses of qPCRs, ergosterol, muramic acid, and LPS (sieved).
‡The number of detected 6 fungal or 2 bacterial qPCRs.
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with each other (around r = 0.90) and also with amount of
dust (around r = 0.85), but correlations between total micro-
bial quantity scores and qPCR results were lower (around
r = 0.30), except for Mycobacterium and the PenAsp group
(around r = 0.50). Diversity score had low correlations with
amount of dust, all microbial markers, and total microbial
quantity scores (around r = 0.20), but higher with Wallemia
sebi (r = 0.66).
A
B
Figure 1 Adjusted associations between amount of dust and bac-
terial (A) and fungal (B) exposure at the age of 2 months and
asthma and respiratory symptoms during the first 6 years of life
and sensitization to inhalant allergen at the age of 6 years. Models
are adjusted for study cohort, farming status, gender, maternal his-
tory of allergic diseases (hay fever, atopic dermatitis, and/or
asthma), smoking during pregnancy, the number of older siblings,
and living area of the home. Models of sensitization to inhalant
allergens (cut point ≥0.70 kU/l) are additionally adjusted for floor
type of dust sampling.
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In general, the associations of single microbial markers with
asthma ever and respiratory symptoms were mostly nonsignif-
icant, while the shape of the association varied (Fig. 1). Total
microbial quantity score had a significant inverted-U-shaped
association with asthma ever: the highest risk for asthma ever
was found with the medium level of total microbial quantity
score and the lowest risk with the highest quantity score
(Fig. 2, Table 3). The association was independent of the
diversity score. The associations were quite similar to current
asthma (Table 3) and when using other microbial markers
than ergosterol, endotoxin, and muramic acid to create the
total microbial quantity score (Table S2) as well as when
using EPS as a marker of fungi (data not shown). Total
microbial quantity scores tended to be inversely associated
with respiratory symptoms (Table S2). The inverted-U-shaped
association between total microbial quantity score and
asthma ever tended to be stronger after adjusting for the
amount of dust (data not shown). Adjustment for dust also
strengthened the associations between asthma, and Strepto-
myces, endotoxin, PenAsp group, b-D-glucan and ergosterol,
but not the other single microbial markers (data not shown).
The associations between total microbial quantity score and
any wheezing were similar among children who were sensitized
against at least one of the tested inhalant or food allergens at
the age of 6 years and who were not sensitized (P-value = 0.66
for interaction term). In contrast, in the stratified analyses, the
inverted-U-shaped associations between the quantity scores
and asthma ever were always stronger among nonatopic than
among atopic children, but the P-values for interaction ranged
between 0.08 and 0.28 (data not shown). There were no inter-
actions with birth cohorts (P-values ≥ 0.27 for interaction
terms). Associations between total microbial quantity score
and any wheezing were also similar in farms and in rural/sub-
urban areas (P-value = 0.58 for interaction term). Due to the
low numbers of children with asthma ever among farmers,
interaction tests between total microbial quantity score and
farming on asthma ever could not be performed.
Diversity score was associated with a decreased risk of any
wheezing, and a similar tendency was seen with asthma ever
and current asthma (Table 3). The association with asthma
ever was, however, fairly sensitive to different adjustments,
especially adjustment for farming. The association with any
wheezing was similar among children from farms and from
rural/suburban areas as well as children who were sensitized
against at least one of the tested inhalant or food allergens at
the age of 6 years and who were not sensitized (P-values
≥ 0.4 for interaction terms) (data not shown).
Most of the associations between single microbial markers
and atopic dermatitis and sensitization to inhalant allergens
at the age of 1 (Table S3) and 6 years (Fig. 1) were nonsig-
nificant. Total microbial quantity score was not associated
with atopic dermatitis or sensitization to inhalant allergen at
the age of either 1 year (data not shown) or 6 years
(Table 3). Diversity score was significantly (inverted-U shape)
associated with sensitization to inhalant allergen at the age of
6 years (Table 3), while similar tendency, though nonsignifi-
cant, was seen with sensitization to inhalant allergen at
1 year (Table S4). No association was found between diver-
sity score and atopic dermatitis (Table S4).
Discussion
The present study suggests that an index of total quantity of
environmental microbial exposure may predict asthma better
than single microbial markers, independently of microbial
diversity score and amount of dust. The diversity score
decreased the risk of wheezing and was significantly
(inverted-U shape) associated with sensitization to inhalant
allergens. Only a few associations were observed between sin-
gle microbial markers and the outcomes studied.
This is the first study using an index of total microbial
quantity score when studying the risk of asthma. Previously,
one cross-sectional study found a tendency of inverse associa-
tion between microbial quantity score (LPS10:0–16:0, ergos-
terol, and muramic acid) and allergic sensitization (9).
Typically, epidemiological studies have used only one micro-
bial marker as a surrogate for total microbial exposure.
However, it is clear that such assessments provide an incom-
plete picture of the total quantity and quality of human
microbial exposure. Due to high correlations, a major diffi-
culty of earlier studies has been to separate the effects of sin-
gle microbial markers from each other and from the effect of
the amount of dust (5, 20). In the present study, total micro-
bial quantity score predicted the risk of asthma indepen-
dently of microbial diversity and amount of dust.
The reason behind the observed association between total
microbial quantity score and asthma is unclear. A potential
explanation is that different components of microbial groups
or genera share common antigen or molecule structures on
their cell wall surface, which are detected by pattern recogni-
tion receptors in innate immunity cells and have a profound
influences on the immune system (21). If total exposure to
Figure 2 Risk of asthma in relation to total microbial quantity score
in quintiles (sum of ergosterol, endotoxin, and muramic acid) (aOR).
Model is adjusted for study cohort, farming status, gender, mater-
nal history of allergic diseases (hay fever, atopic dermatitis, and/or
asthma), smoking during pregnancy, the number of older siblings,
living area of the home, and diversity score.
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such structures is the main causal factor explaining the asso-
ciation between microbial exposure and lower risk of allergic
diseases, then total microbial quantity score is likely to better
reflect this exposure than single microbial markers. Varying
correlations of single microbial markers with total microbial
exposure would then explain the often weak and conflicting
findings from earlier studies. In addition, some studies have
shown synergistic interactions between different exposing
agents (22), and an index of total microbial quantity score
may capture such synergistic effects. Data from deep
sequencing of microbial exposure (23) will give opportunities
to explore further the above potential mechanisms.
Total microbial quantity score had an inverted-U-shaped
association with asthma. Previous studies have suggested that
the immune system may react first with enhanced response
and subsequently with tolerance (24). Associations of similar
shape have also been reported earlier between allergen levels
and b-D-glucan, and risk of asthma, wheezing, or atopic sen-
sitization (25–27). The shape of the association in the present
study may also relate to some unknown characteristics of the
present study, given that some single microbial markers also
showed an association of a similar shape. Further studies in
larger cohorts and in different settings are needed to better
define the shape of the association between total microbial
quantity score and risk of asthma.
We found a similar inverse association between measured
microbial diversity score and wheezing, as has been reported
with asthma in two recent cross-sectional studies (8). The asso-
ciation with asthma was nonsignificant, though in the same
direction. There were differences in the microbiological meth-
ods used between the present study and previous studies. We
used qPCR, a method that quantitatively describes the pres-
ence of specific viable and nonviable organisms of prior chosen
microbes (28). The previous studies either cultivated viable
microbes (GABRIELA study) or used single-strand conforma-
tion polymorphism analyses, which is a qualitative rather than
quantitative method (PARSIFAL study) (8). We calculated a
diversity score based on 6 fungal and 2 bacterial qPCR assays
representing either microbial species, genera, or groups, which
hence only provides a suggestive and rough estimate of the
overall microbial diversity. Nonetheless, the results are in line
with previous studies (8) targeting a broader spectrum of
microbes. Taken together, the studies suggest that microbial
diversity score may predict asthma and may be a useful marker
to describe the quality of microbial exposure.
The observed associations between studied health out-
comes and single microbial markers should be interpreted
with caution, as no adjustments for multiple testing were
done. The most interesting findings were maybe the protec-
tive associations in the case of Gram-positive bacteria (Myco-
bacterium spp., Streptomyces spp., and muramic acid), which
have been reported earlier for muramic acid (6, 29).
The main strengths of the present study are the prospective
birth cohort design with high participation rate (varied
between 80% and 95% in each follow-up) and a good variety
of measured markers of exposure to environmental microbes.
The small size of our study cohort is the main limitation of
the study, and the results need to be confirmed in further stud-
ies. The microbial markers and combinations of those used to
build total microbial quantity scores in the present study
do not measure total microbial exposure without error, for
example using muramic acid together with endotoxin overesti-
mates the amount of Gram-negative bacteria, because muramic
acid is found also in Gram-negative bacteria, although to a
lesser extent (30). These weaknesses do not, however, appear to
be a major problem, as the different quantity scores used in the
present study showed very similar associations.
In conclusion, our indicator for total quantity of microbial
exposure predicted asthma better than single microbial mark-
ers. Detected associations were independent of the measured
microbial diversity and amount of dust. Better indicators of
total quantity and diversity of microbial exposure are needed
in studies on the development of asthma.
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